Follow
Elena Vendrame
Elena Vendrame
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Human natural killer cells mediate adaptive immunity to viral antigens
R Nikzad, LS Angelo, K Aviles-Padilla, DT Le, VK Singh, L Bimler, ...
Science immunology 4 (35), eaat8116, 2019
1632019
HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma
M Epeldegui, E Vendrame, O Martínez-Maza
Immunologic research 48, 72-83, 2010
1022010
Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk
E Vendrame, SK Hussain, EC Breen, LI Magpantay, DP Widney, ...
Cancer epidemiology, biomarkers & prevention 23 (2), 343-349, 2014
872014
A novel human IL2RB mutation results in T and NK cell–driven immune dysregulation
IZ Fernandez, RM Baxter, JE Garcia-Perez, E Vendrame, T Ranganath, ...
Journal of Experimental Medicine 216 (6), 1255-1267, 2019
772019
Serum Levels of the Chemokine CXCL13, Genetic Variation in CXCL13 and Its Receptor CXCR5, and HIV-Associated Non-Hodgkin B-Cell Lymphoma Risk
SK Hussain, W Zhu, SC Chang, EC Breen, E Vendrame, L Magpantay, ...
Cancer epidemiology, biomarkers & prevention 22 (2), 295-307, 2013
702013
Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma
E Vendrame, O Martínez-Maza
Journal of proteome research 10 (1), 113-119, 2011
622011
TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells
E Vendrame, C Seiler, T Ranganath, NQ Zhao, R Vergara, M Alary, ...
AIDS 34 (6), p 801-813, 2020
452020
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
D SenGupta, C Brinson, E DeJesus, A Mills, P Shalit, S Guo, Y Cai, ...
Science translational medicine 13 (599), eabg3071, 2021
442021
Mass cytometry analytical approaches reveal cytokine‐induced changes in natural killer cells
E Vendrame, J Fukuyama, DM Strauss‐Albee, S Holmes, CA Blish
Cytometry Part B: Clinical Cytometry 92 (1), 57-67, 2017
412017
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes
C Gattazzo, A Teramo, M Miorin, E Scquizzato, A Cabrelle, M Balsamo, ...
Haematologica 95 (10), 1722, 2010
292010
Natural killer cell phenotype is altered in HIV-exposed seronegative women
NQ Zhao, E Vendrame, AM Ferreira, C Seiler, T Ranganath, M Alary, ...
PloS One 15 (9), e0238347, 2020
222020
Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry
T Ranganath, LJ Simpson, AM Ferreira, C Seiler, E Vendrame, N Zhao, ...
Frontiers in immunology 11, 513878, 2020
162020
CytoGLMM: conditional differential analysis for flow and mass cytometry experiments
C Seiler, AM Ferreira, LM Kronstad, LJ Simpson, M Le Gars, E Vendrame, ...
BMC bioinformatics 22, 1-14, 2021
152021
Uncertainty quantification in multivariate mixed models for mass cytometry data
C Seiler, LM Kronstad, LJ Simpson, ML Gars, E Vendrame, CA Blish, ...
arXiv preprint arXiv:1903.07976, 2019
112019
Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical …
ATG Fernandes, NP Rocha, E Vendrame, F Russomano, BJ Grinsztejn, ...
Apoptosis 20, 1347-1357, 2015
112015
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients
E Castellano, M Valés‐Gómez
Frontiers in Immunology 13, 970931, 2022
72022
Profiling of the human natural killer cell receptor-ligand repertoire
E Vendrame, JL McKechnie, T Ranganath, NQ Zhao, A Rustagi, ...
JoVE (Journal of Visualized Experiments), e61912, 2020
72020
Uncertainty Quantification in Multivariate Mixed Models for Mass Cytometry Data. arXiv [stat. AP]
C Seiler, LM Kronstad, LJ Simpson, M Le Gars, E Vendrame, CA Blish, ...
61903
Natural killer cell receptors and ligands are associated with markers of HIV-1 persistence in chronically infected ART suppressed patients
GT Ivison, E Vendrame, GJ Martínez-Colón, T Ranganath, R Vergara, ...
Frontiers in Cellular and Infection Microbiology 12, 757846, 2022
52022
A pooled analysis of eight clinical studies suggests a link between influenza-like adverse events and pharmacodynamics of the toll-like receptor 7 agonist vesatolimod
S Riddler, Y Cai, E Vendrame, Y Zheng, L Zhang, D Verrill, X Liu, ...
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 108-109, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20